/Companies

Econic Biosciences

London, GB · 1 known investors

Find your way into Econic Biosciences

Sign up to see every warm intro you have to Econic Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Econic Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Econic Biosciences is a biotech company developing cancer therapies that target extrachromosomal DNA (ecDNA), a driver of oncogene amplification and tumor evolution. It uses computational and analytical tools to identify and validate ecDNA-related therapeutic targets for treating cancer patients across diagnoses.

Founders & leadership

RLRalph Lindemann
Ralph LindemannChief Scientific Officer
PJ
Pete JohnsonHead of Medicinal Chemistry
SWSteven Whittaker
Steven WhittakerHead of Biology
AHAlastair Hamilton
Alastair HamiltonHead of Business Operations & Strategy

Board

RN
Rodger NovakExecutive ChairmanVenture Partner at SR One Capital Management

Investors · 1

Companies House · registry record

View on Companies House ↗
Registered name
ECONIC BIOSCIENCES LIMITED
Company number
13806907
Status
Active
Company type
Private limited company
Incorporated
17 Dec 2021
Registered office
Suites 3 & 4, Waterfront Building Manbre Wharf, Hammersmith, London, W6 9RU
Nature of business (SIC)
64303 — Activities of venture and development capital companies
Previous names
AMZL THERAPEUTICS LIMITED (2022–2023)AMZL LIMITED (2021–2022)
Accounts
last made up to 31 Dec 2025 · next due 30 Sept 2027
Confirmation statement
last made up to 16 Dec 2025 · next due 30 Dec 2026

Current officers · 5

  • Josephine Angela Stevens — secretary, appointed 19 Jan 2023
  • Shaun Patrick Foy — director, appointed 17 Dec 2021
  • Mahesh Kudari — director, appointed 17 Jul 2025
  • Iqbal Mufti — director, appointed 17 Jul 2025
  • Rodger Novak — director, appointed 28 Mar 2022

Source: Companies House public register · retrieved 20 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Econic Biosciences do?
Econic Biosciences is a biotech company developing cancer therapies that target extrachromosomal DNA (ecDNA), a driver of oncogene amplification and tumor evolution. It uses computational and analytical tools to identify and validate ecDNA-related therapeutic targets for treating cancer patients across diagnoses.
Who are Econic Biosciences's investors?
Econic Biosciences's investors include SR One Capital Management.
Where is Econic Biosciences headquartered?
Econic Biosciences is headquartered in London, GB.